SHARE

PODCAST May 24, 2022

Innovation in Higher Education, Perspectives from a Pharma CEO - With Dr. David Bearss of U2TAH Therapeutics Accelerator

You've Reached Your
Free Article Limit This Month
Register for free to get unlimited access to all Law.com OnPractice content.
Register Now

Key Takeaways

  • Dr. Bearss discusses advancements in the pharmaceutical industry throughout his career, new initiatives being implemented in connection with the University of Utah, and economic development throughout the country.

This episode is part of an ongoing series where we interview leaders who are striving to grow economic development in their area. In this episode, we're joined by Dr. David Bearss, Senior Managing Director at the U2TAH Therapeutics Accelerator. Dr. Bearss discusses advancements in the pharmaceutical industry throughout his career, new initiatives being implemented in connection with the University of Utah, and economic development throughout the country.

Scott Marty, co-leader of our Life Science Industry Group, hosts the conversation.

ALM expressly disclaims any express or implied warranty regarding the OnPractice Content, including any implied warranty that the OnPractice Content is accurate, has been corrected or is otherwise free from errors.

More From Ballard Spahr

New York Restricts Automated Decision Making in Employment

By Timothy Dickens Ballard Spahr August 29 , 2022

Businesses operating in New York City should be aware of a local law addressing the use of automated employment screening and decision-making tools coming into effect on January 1, 2023.

Status Update: Federal Contractor Vaccine Mandate Injunction Narrowed

By Lila A. Sevener Ballard Spahr August 29 , 2022

On August 26, 2022, the United States Court of Appeals for the Eleventh Circuit narrowed the nationwide injunction of Executive Order 14042, which requires federal contractors and employees who work on or in connection with a covered federal contract, or share a workplace with another employee who works on or in connection with such contracts, to be fully vaccinated against COVID-19.

Unions Cannot Force OSHA to Issue Permanent COVID Standard

By Shannon D. Farmer Ballard Spahr August 26 , 2022

On August 26, 2022, the U.S. Court of Appeals for the District of Columbia Circuit turned back efforts by a group of unions seeking to force the Occupational Safety and Health Administration (OSHA) to quickly issue a permanent rule establishing protections for healthcare workers from COVID-19.

More From Pharmaceuticals

Claims of Benzene in Dry Shampoo: New Citizen Petition on Products Poses Significant Litigation Risk

By Michael T. Baier Greenberg Traurig November 09 , 2022

On Oct. 31, 2022, Valisure LLC submitted a Citizen Petition to the U.S. Food and Drug Administration (FDA) requesting, inter alia, a recall of dry shampoo products containing benzene.

5 Ways Sponsors Can Prepare for Increased Clinical Trial Fraud Scrutiny

By George M. Karavetsos Buchanan Ingersoll & Rooney October 04 , 2022

Clinical trial fraud has come under the microscope at two of the largest federal overseers – and life sciences companies need to take notice.

FDCA's Exclusive Enforcement Provision Reigns Supreme over State Laws

By Cecilia Choy, Ph.D. McDermott Will & Emery September 29 , 2022

In its first occasion to interpret § 353b of the Federal Food, Drug, and Cosmetic Act (FDCA), the US Court of Appeals for the Ninth Circuit relied on the “implied preemption doctrine” to affirm a district court’s case dismissal for failure to state a claim under Fed. R. Civ. P. 12(b)(6).

Featured Stories
Closeclose
Search
Menu

Working...